Visualization and In Situ Ablation of Intracellular Bacterial Pathogens through Metabolic Labeling

Protected by the host cells, the hidden intracellular bacteria are typically difficult to kill by common antibiotics and cannot be visualized without complex cellular pretreatments. Herein, we successfully developed a bacteria‐metabolizable dual‐functional probe TPEPy‐d‐Ala, which is based on d‐alanine and a photosensitizer with aggregation‐induced emission for fluorescence turn‐on imaging of intracellular bacteria in living host cells and photodynamic ablation in situ. Once metabolically incorporated into bacterial peptidoglycan, the intramolecular motions of TPEPy‐d‐Ala are inhibited, leading to an enhanced fluorescent signal, which allows the clear visualization of the intracellular bacteria. Moreover, TPEPy‐d‐Ala can effectively ablate the labeled intracellular bacteria in situ owing to covalent ligation to peptidoglycan, yielding a low intracellular minimum inhibitory concentration (MIC) of 20±0.5 μg mL−1, much more efficient than that of a commonly used antibiotic, vancomycin. Search and destroy: A bacteria‐metabolizable probe, TPEPy‐d‐Ala, was designed to covalently label intracellular bacteria in living host cells. Additionally, the probe can effectively ablate the labeled bacteria in situ owing to covalent ligation to peptidoglycan, yielding a minimum inhibitory concentration of 20±0.5 μg mL−1, which is lower than that of vancomycin.